explore -WSS

explore

author：Wikipedia 2025-08-23 10:39:07 - browse：67

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： TikTok cracks down on users posting about weight loss drugs

WSS

Use doctors trained outside the U.S. to ease the physician shortage

Hubble vs. James Webb telescope images: See the difference

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

Hubble vs. James Webb telescope images: See the difference

Fatty liver disease was alleviated by Lilly’s ‘triple

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

hotspot

explore

leisure time

At least 13 dead in Texas as scorching temps continue

Man who had jail sentence commuted by Trump arrested again

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Dobbs anniversary: the lost opportunity of abortion as health care

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

At least 13 dead in Texas as scorching temps continue

The wait for US passports is creating travel purgatory and snarling summer plans

Medicare proposal to cover medical devices draws a mixed reaction

Fatty liver disease was alleviated by Lilly’s ‘triple

knowledge

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Undocumented workers face uncertainty as immigration law takes effect in Florida

Researchers separate signal from noise in heart wearable data

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Crowdfunding for unproven stem cell procedures spreads misinformation

Stanford president to resign after investigation of research

hotspot

knowledge

focus

leisure time